Tehran (IP)- The Head of Research Team of the Execution of Imam Khomeini's Order (EIKO), announced the readiness for the second and third phases of the clinical study of the COV Iran Barkat vaccine.

Iran Press/Iran News:  In an interview with Iran Press on the sidelines of the first phase of clinical studies of COV Iran Barakat vaccine, Hassan Jalili added that the time of completion of phase one clinical study of the Iranian vaccine COV Iran Barakat has ripped.

The proposed clinical study plan for this vaccine for the second and third phases would soon be sent to Iran's Ministry of Health. Jalili said the results of a phase one clinical trial of the COV Iran Barakat vaccine would also be sent to Iran's Ministry of Health.

On the effectiveness of the Iranian vaccine on the UK virus variant, Jalili said, "This is completely an Iranian vaccine that has the ability to neutralize the British virus variant."


"COV Iran Barkat" vaccine is ready to enter second stage of human trial